SHARE
Facebook X Pinterest WhatsApp

FDA Clears Aneurysm Detecting Artificial Intelligence Tool

thumbnail
FDA Clears Aneurysm Detecting Artificial Intelligence Tool

Dual View of Real MRI Scans of the Head and Brain

Compared to slow, manual processes, the hope is that the AI-based system will catch the signs of aneurysm earlier and with greater frequency.

Apr 29, 2022

Viz.ai continues its work at the intersection of artificial intelligence and healthcare with a new FDA greenlight: an algorithm that spots cerebral aneurysms. It gained recognition previously for its work in the early detection of strokes.

The company’s system analyzes scans for signs of weakened or distended blood vessels, a known cause of aneurysms. Once detected, the system automatically notifies neurovascular specialists to confirm and process the next steps. The system helps experts detect the signs of aneurysms earlier to prevent catastrophic outcomes.

Manual detection is slow, and humans can sometimes miss signs due to outside factors like fatigue or distraction. With machines, powerful processing capability helps ensure details don’t get missed—something that could save more people each year, considering around 3% of the population currently carry the conditions for an aneurysm.

With AI powering the bulk of data processing, the hope is to catch the signs of aneurysm earlier and with greater frequency without additional labor on physicians and specialists who are already swamped with patients. Machines are capable of examining a significant number of images in a short period of time, while humans can step in to manage diagnosis and treatment.

See also: Innovative Ways Cloud Computing Is Impacting Healthcare

The new artificial intelligence model adds to the digital care coordination platform

The platform covers ischemic and hemorrhagic stroke, cerebral perfusion, pulmonary embolisms, and aortic disease for more than 1,000 hospitals. It’s part of a long history of AI-driven healthcare initiatives for which the company has raised millions of dollars in funding. Its first computer triage program has already gained EU approval.

The company will be partnering with remote care provider TeleSpecialists to provide virtual consultations with neurologists for providers on the ground that may not have access to a wide range of specialists. The companies will also offer additional hospital workflows, as well as research collaboration in this and other areas of healthcare. It’s one more way artificial intelligence is helping every industry make human life a priority.

thumbnail
Elizabeth Wallace

Elizabeth Wallace is a Nashville-based freelance writer with a soft spot for data science and AI and a background in linguistics. She spent 13 years teaching language in higher ed and now helps startups and other organizations explain - clearly - what it is they do.

Recommended for you...

AI Agents Need Keys to Your Kingdom
The Rise of Autonomous BI: How AI Agents Are Transforming Data Discovery and Analysis
Why the Next Evolution in the C-Suite Is a Chief Data, Analytics, and AI Officer
Digital Twins in 2026: From Digital Replicas to Intelligent, AI-Driven Systems

Featured Resources from Cloud Data Insights

The Difficult Reality of Implementing Zero Trust Networking
Misbah Rehman
Jan 6, 2026
Cloud Evolution 2026: Strategic Imperatives for Chief Data Officers
Why Network Services Need Automation
The Shared Responsibility Model and Its Impact on Your Security Posture
RT Insights Logo

Analysis and market insights on real-time analytics including Big Data, the IoT, and cognitive computing. Business use cases and technologies are discussed.

Property of TechnologyAdvice. © 2026 TechnologyAdvice. All Rights Reserved

Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.